Skip to content
Home » Explore » Bayer Holding Co., Ltd. Bayer Yakuhin holds disease awareness event “Learn about diabetes and complications through an experiential board game – Listen to your kidneys – in Marunouchi”

Bayer Holding Co., Ltd. Bayer Yakuhin holds disease awareness event “Learn about diabetes and complications through an experiential board game – Listen to your kidneys – in Marunouchi”

  • All

[Bayer Holding Co., Ltd.] Bayer Yakuhin holds disease awareness event “Learn about diabetes and complications through an experiential board game – Listen to your kidneys – in Marunouchi” ​
Bayer Holding Co., Ltd. Press release: November 11, 2024 Bayer Yakuhin holds disease awareness event “Learn about diabetes and complications through an experiential board game – Listen to your kidneys – in Marunouchi” Comedy duo
“Gambareruya” guest appearance ●A super-sized hands-on board game has appeared in Marunouchi, Tokyo, where you can have fun while taking the diabetes/complications quiz! ●Nearly 1,000 people participated and watched the event on November 7th and 8th ●November 14th is “World Diabetes Day” Osaka, November 11, 2024 -Bayer Yakuhin Co., Ltd. (Headquarters: Osaka City, President and CEO: Ying Chen, hereinafter referred to as “Bayer Yakuhin”) has announced the “Learn Diabetes with Hands-On Board Game” as part of its awareness activities regarding diabetes and its complications. and Complications ~Let’s listen to the voice of the kidneys~ in Marunouchi” was held in Tokyo on November 7th and 8th, 2024. Nearly 1,000 people attended the event, which was held in advance of World Diabetes Day (formerly World Diabetes Day) on November 14th, and the event was attended by a total of nearly 1,000 people, who learned about diabetes and its complications through oversized board games spread across the floor of the venue. I have deepened my understanding of
https://prcdn.freetls.fastly.net/release_image/76998/92/76998-92-bc4f256c6734b349defc6290d1f481c5-3566×2377.jpg

From left: Yusuke Nakamura, Director of Bayer Pharmaceutical Market Access & Public Affairs Headquarters, Yoshiko and Mahiru, Gambararuya, and Dr. Ryotaro Bouchi, Chief Diabetes Surgeon, National Center for Global Health and Medicine At the opening event on the first day (7th), a talk session was held with Dr. Ryotaro Bouchi, Director of the First Diabetes Department at the National Center for Global Health and Medicine, who specializes in diabetes, and Yoshiko and Mahiru of the comedy duo “Gambaruya”. I did. Dr. Bonai gave an
easy-to-understand explanation about diabetes and its complications, including answers to questions from the two Gambararuya guests. ■Let’s talk more about treatment with the doctor Dr. Bonai listed
retinopathy, nephropathy, and neuropathy as the three major
complications of diabetes, and noted that diabetic nephropathy does not have any noticeable symptoms until it is quite advanced. “Let’s do regular tests, especially urine tests, and listen carefully to the “voice of the kidneys,” which is also the title of this event.” When the two members of Gambareruya were introduced to the symptoms of kidney failure, Yoshiko said, “I get short of breath when I move even a little.My whole family loves fried foods, too.” Mr. Mahiru, who had a number of items to choose from, was convinced of the importance of early detection, saying, “It’s important to go to the hospital and get regular tests because symptoms are hard to notice.”
https://prcdn.freetls.fastly.net/release_image/76998/92/76998-92-3a7719897a156b001c327643027ef861-3900×2600.jpg Dr. Bonai also points out that it is important for patients to develop diabetes or diabetic nephropathy, which will be with them for a long time, to be able to receive treatment proposals that are suitable for them from their doctors. It is important for patients to be more proactive in communicating with medical professionals about their daily lives, small changes in their lives, things they are good at and things they are not good at, etc.,” he suggested. Mahiru, who received the advice, said, “I found it very helpful to learn that it’s important to prepare notes in advance because sometimes I get nervous and can’t speak when I meet the teacher face-to-face. At the hospital, I will do my best to communicate well with the doctor.”Yoshiko also said, “The reason why my family doctor often asks me about the contents of my Rokeben is because of how I look in my daily diet.” “Maybe he was listening to me kindly to see if I could make any changes to my health,” he said, showing his enthusiasm to put what he learned today to use in order to prevent diabetes and complications.
https://prcdn.freetls.fastly.net/release_image/76998/92/76998-92-4b41aefc68de8f92f4dd7681af7d322f-3900×2600.jpg
https://prcdn.freetls.fastly.net/release_image/76998/92/76998-92-cf2c3e849f166df96d2623708bbd7aea-3900×2600.jpg
https://prcdn.freetls.fastly.net/release_image/76998/92/76998-92-e4e00db52cb1509405eced52ee7ad812-3900×2600.jpg ■ The oversized board game where visitors walk through the squares themselves was a big hit At this event, what caught my eye even from a distance was the extra-large board game spread across the entire floor of the venue. Participants rolled dice and spun a roulette wheel like Sugoroku, moving forward and aiming for the goal while answering quizzes about diabetes and complications written on the squares they stopped at. The two Gambareruyas who tried the board game were also excited about its size. Regarding diabetic nephropathy, which was a topic of discussion during the talk session with Dr. Bonai, Mahiru took on the quiz question “What is the percentage of dialysis patients who have diabetic nephropathy?” and immediately answered “about 40%.” Answer the quiz correctly. “Wow, Ma-chan remembers me!” Yoshiko complimented her, making her happy. After crossing the finish line, the two of them sat together in a photo frame and shared their impressions of the board game, saying, “It was so much fun! When I turned the roulette wheel, the message “Jump 10 times” appeared, and I was out of breath again.” (Yoshiko) ), “It’s good to be able to learn while having fun,” said Mahiru.
https://prcdn.freetls.fastly.net/release_image/76998/92/76998-92-ba74be169db2be7601ffcef328897ad5-3900×2600.jpg Even among the general participants, through the board game quizzes, we could see them being surprised and saying, “I didn’t know that,” and nodding their heads and saying, “I’m going to keep this in mind.” There were also some people eagerly looking at the exhibition panels with great interest. Bayer Yakuhin hopes that this event will be an opportunity to deepen understanding of diabetes and its complications, and to lead to prevention and early detection. “Learn about diabetes and its complications through a hands-on board game – Listen to the voice of your kidneys – in Marunouchi” Date and time: November 7th (Thursday), November 8th (Friday) 11:00~19:00 Location: Maru Building 1st floor Maru Cube (2-4-1 Marunouchi, Chiyoda-ku, Tokyo) “An extra-large experiential board game has appeared in Marunouchi!” A system in which visitors can walk through the squares and learn about diabetes and complications (CKD) in the form of quizzes. Use the exhibition panels as a hint and have fun while GOAL!
https://prcdn.freetls.fastly.net/release_image/76998/92/76998-92-948fc69bbeb9533f422d9d84ab9cdbe3-2111×1242.jpg [About diabetes and complications] It is estimated that there are approximately 20 million people in total who are strongly suspected of having diabetes (diabetes) and those for whom the possibility of diabetes cannot be denied (prediabetes) (*1), including prediabetes. Diabetes is said to be a national disease that affects one in five to six Japanese people. On the other hand, there are some people who have a hard time becoming self-centered and do not take appropriate tests and are unaware that they have diabetes, and some who are unable to continue seeing a doctor and discontinue treatment after being diagnosed with diabetes (*2). I have a challenge. In addition, diabetic nephropathy, which is a complication of diabetes that can occur due to continued high blood sugar levels, can be referred to as chronic kidney disease (CKD), which is a complication of diabetes. Diabetic nephropathy is the most common disease causing dialysis, accounting for approximately 40% (*3) of patients newly undergoing dialysis. Kidney function declines over a long period of 10 to 20 years after developing diabetes, so early detection and
countermeasures are important for controlling the disease’s
progression and allowing you to continue your daily life. References: *1.Ministry of Health, Labor and Welfare. 2016 “National Health and Nutrition Survey” *2. National Center for Global Health and Medicine Diabetes Information Center *3. Japanese Society of Dialysis Medicine. Current status of chronic dialysis therapy in Japan (as of December 31, 2022) November 14th About World Diabetes Day World Diabetes Day (formerly World Diabetes Day) is a diabetes awareness day in which more than 1 billion people from 160 countries around the world participate. This is an important opportunity to raise awareness about the importance of prevention and continued treatment. For details, please visit https://www.wdd.jp/ Please refer to
https://prcdn.freetls.fastly.net/release_image/76998/92/76998-92-b4d00de77c5ba5add081f11be6fb81b2-2048×1331.png About Bayer’s commitment in cardiovascular and renal diseases As an innovative leader in cardiovascular disease, Bayer has a long-standing commitment to delivering science for a better life through a portfolio of innovative treatments. The heart and kidneys are closely connected in health and disease, and Bayer is working across a wide range of fields to develop new therapeutic approaches for cardiovascular and kidney diseases, which have high unmet medical needs. Bayer’s cardiovascular franchise has many products and several other compounds in various stages of preclinical and clinical development. These products and compounds reflect Bayer’s approach to preferentially develop targets and signaling pathways that have the potential to impact treatments for cardiovascular diseases. About Bayer Bayer is a global company whose core businesses are in the health care and food-related life science fields. In line with our mission “Health for all, Hunger for none”, Bayer products and services help us overcome the key challenges posed by a growing and aging world population. By supporting these initiatives, we are contributing to people’s lives and the prosperity of the planet. Bayer is committed to promoting sustainable development and creating a positive impact through our business. At the same time, we aim to increase profitability and create corporate value through innovation and growth. The Bayer brand is a symbol of trust, reliability and quality around the world. In 2023, the Group will have sales of 47.6 billion euros, approximately 100,000 employees and R&D expenses before special items of 5.8 billion euros. For more information, please visit Please refer to About Bayer Yakuhin Co., Ltd. Through our pharmaceutical and consumer health businesses, we are promoting sustainable initiatives that transform treatment for patients in Japan. The medical
pharmaceuticals division specializes in cardiovascular, renal, and metabolic fields, oncology, ophthalmology, gynecology, hematology, and diagnostic imaging, while the consumer health division focuses on proper nutrition for a baby’s “first 1000 days of life.” In order to deliver this, we are focusing on supplements that support women’s pregnancy preparation and pregnancy period. For more information, please visit , Facebook , YouTube Please refer to Bayer Yakuhin Co., Ltd. November 11, 2024, Osaka Forward-Looking Statements This news release may contain forward-looking statements that are based on Bayer’s management’s current estimates and expectations. Various known and unknown risks, uncertainties and other factors may cause material differences between future results, financial condition, trends or results of the company and those projected in this document. These factors include: ” target=”_blank” rel=”nofollow ugc noopener”> ) includes those described in the report published in ). The Company assumes no responsibility to update these forward-looking statements or conform them to future events or circumstances.

This article was partly generated by AI. Some links may contain Ads. Press Release-Informed Article.